Your browser doesn't support javascript.
loading
Outcome of surgery in advanced ovarian cancer varies between geographical regions; opportunities for improvement in The Netherlands.
Timmermans, M; Sonke, G S; Slangen, B F M; Baalbergen, A; Bekkers, R L M; Fons, G; Gerestein, C G; Kruse, A J; Roes, E M; Zusterzeel, P L M; Van de Vijver, K K; Kruitwagen, R F P M; van der Aa, M A.
Afiliação
  • Timmermans M; Department of Research, Netherlands Comprehensive Cancer Organization (IKNL), Utrecht, the Netherlands; Department of Obstetrics and Gynaecology, Maastricht University Medical Centre, Maastricht, the Netherlands; GROW, School for Oncology and Developmental Biology, Maastricht, the Netherlands. Elect
  • Sonke GS; Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.
  • Slangen BFM; Department of Obstetrics and Gynaecology, Maastricht University Medical Centre, Maastricht, the Netherlands; GROW, School for Oncology and Developmental Biology, Maastricht, the Netherlands.
  • Baalbergen A; Department of Obstetrics and Gynaecology, Reinier de Graaf Hospital, Delft, the Netherlands.
  • Bekkers RLM; Department of Obstetrics and Gynaecology, Catharina Hospital, Eindhoven, the Netherlands.
  • Fons G; Department of Obstetrics and Gynaecology, Academic Medical Centre, Amsterdam, the Netherlands.
  • Gerestein CG; Department of Obstetrics and Gynaecology, Meander Medical Centre, Amersfoort, the Netherlands.
  • Kruse AJ; Department of Obstetrics and Gynaecology, Maastricht University Medical Centre, Maastricht, the Netherlands; GROW, School for Oncology and Developmental Biology, Maastricht, the Netherlands; Department of Obstetrics and Gynaecology, Isala Hospital, Zwolle, the Netherlands.
  • Roes EM; Department of Obstetrics and Gynaecology, Erasmus Medical Centre, Rotterdam, the Netherlands.
  • Zusterzeel PLM; Department of Obstetrics and Gynaecology, Radboud University Medical Centre, Nijmegen, the Netherlands.
  • Van de Vijver KK; Department of Pathology, Ghent University Hospital, Cancer Research Institute Ghent (CRIG), Ghent, Belgium.
  • Kruitwagen RFPM; Department of Obstetrics and Gynaecology, Maastricht University Medical Centre, Maastricht, the Netherlands; GROW, School for Oncology and Developmental Biology, Maastricht, the Netherlands.
  • van der Aa MA; Department of Research, Netherlands Comprehensive Cancer Organization (IKNL), Utrecht, the Netherlands.
Eur J Surg Oncol ; 45(8): 1425-1431, 2019 Aug.
Article em En | MEDLINE | ID: mdl-31027945
ABSTRACT

INTRODUCTION:

The care for patients with epithelial ovarian cancer(EOC) is organised in eight different geographical regions in the Netherlands. This situation allows us to study differences in practice patterns and outcomes between geographical regions for patients with FIGO stage IIIC and IV.

METHODS:

We identified all EOC patients who were diagnosed with FIGO stage IIIC or IV between 01.01.2008 and 31.12.2015 from the Netherlands Cancer Registry. Descriptive statistics were used to summarize treatment and treatment sequence(primary cytoreductive surgery(PCS) or neoadjuvant chemotherapy and interval cytoreductive surgery(NACT-ICS)). Moreover, outcome of surgery was compared between geographical regions. Multilevel logistic regression was used to assess whether existing variation is explained by geographical region and case-mix factors.

RESULTS:

Overall, 6,741 patients were diagnosed with FIGO IIIC or IV disease. There were no differences in the percentage of patients that received any form of treatment between the geographical regions(range 80-86%, P = 0.162). In patients that received cytoreductive surgery and chemotherapy, a significant variation between the geographical regions was observed in the use of PCS and NACT-ICS(PCS 24-48%, P < 0.001). The percentage of complete cytoreductive surgeries after PCS ranged from 10 to 59%(P < 0.001) and after NACT-ICS from 37 to 70%(P < 0.001). Moreover, geographical region was independently associated with the outcome of surgery, also when adjusted for treatment sequence(P < 0.001).

CONCLUSION:

We observed a significant variation in treatment approach for advanced EOC between geographical regions in the Netherlands. Furthermore, the probability to achieve no residual disease differed significantly between regions, regardless of treatment sequence. This may suggest that surgical outcomes can be improved across geographical regions.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Ovariectomia / Sistema de Registros / Carcinoma Epitelial do Ovário Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Middle aged País/Região como assunto: Europa Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Ovariectomia / Sistema de Registros / Carcinoma Epitelial do Ovário Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Middle aged País/Região como assunto: Europa Idioma: En Ano de publicação: 2019 Tipo de documento: Article